Dennis Weibling, Former Nextel CEO, Joins Cool Planet’s Board of Directors

Weibling Will Chair Cool Planet’s Audit Committee as Company Begins Building its First Commercial Biorefinery

GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Cool Planet, a company transforming agricultural waste into gasoline, diesel, and CoolTerra™ biocarbon, announced the addition of Dennis Weibling to its board of directors. In addition to Weibling joining the board, he will also serve as Chairman of the audit committee.

Weibling, the managing director of Rally Capital LLC, a venture capital firm based in Kirkland, Wash., has been a global leader in the telecommunications industry. He has served on the board of more than 10 companies, including Sotheby’s board as chairman of the audit and finance committees, a position he’s held since 2006. He joins the Cool Planet board to replace Tony Radaich.

“We want to thank Tony Radaich for his service to the board. Tony served as one of our original independent board members,” said Cool Planet CEO Howard Janzen.

Weibling joins other experienced directors at Cool Planet, including Former ConocoPhillips Chairman Archie Dunham, former Arkansas Lieutenant Governor William Halter, and former BP and Mobil technology lead Ron Sills as the fourth independent member of the board of directors.

“Dennis will bring wisdom gained from decades of business and board leadership to help advance our pre-IPO company,” said Janzen. “Cool Planet will benefit from Dennis’s global experience as we look to add additional strategic partners, and from his financial oversight for building a long-term, sustainable corporation.”

“Cool Planet has the right technology, a strong leadership team, and is ready to commercialize their breakthrough technology,” said Weibling. “I look forward to advising the company as it grows, and drives innovation into the energy, water, and agriculture markets.”

Weibling was president of Eagle River, Inc. from 1993 to 2001, and as vice chairman of Eagle River Investments from 2002 to 2004. He served as CEO of Nextel Communications Inc. from 1995 to 1996 and as a Director of Nextel from 1995 until 2004. At Nextel, he was a member and chairman of the operations, audit, finance, and compensation committees at various times during that period. Weibling served as a board member of Nextel Partners from 1998 to 2006 and chaired the audit committee. He also served on the board of public company XO Communications, Inc. from 1996 to 2003 on the compensation and audit committee.

Weibling served as a Trustee for Seattle Pacific University from 2002 to 2013 and as Chair his last four years. He earned his CPA credential and was a partner at Clark Nuber & Co in Bellevue, Wash. from 1986 to 1993. Weibling received his bachelor’s degree from Wittenberg University in Springfield, Ohio and his Juris Doctor and master’s degrees from the University of Nebraska.

About Cool Planet

Cool Planet is commercializing a technology to create high-octane gasoline, jet, diesel or chemicals from agricultural residues. Its CoolTerra™ product increases crop productivity and promotes more robust plant health while reducing fertilizer and water requirements. The process is capable of being carbon-negative, reversing the consequences of carbon dioxide build-up from fossil fuels. Cool Planet’s technology has a broad portfolio of pending and granted patents. Strategic investors include BP, Google Ventures, Energy Technology Ventures (GE, NRG and Conoco Phillips), the Constellation division of Exelon, and leading venture capital investors, including North Bridge Venture Partners.

Visit Cool Planet at www.coolplanet.com; On Twitter: @CoolPlanetFuels; On Facebook: facebook.com/CoolPlanetEnergySystems.

Find more about the CoolTerra™ product at www.coolterra.com; On Twitter: @CoolTerraNews; On Facebook: facebook.com/CoolTerraNews.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150528005182/en/

Cool Planet
Wesley Bolsen, 303-221-2029
[email protected]

Source: Cool Planet

You May Also Be Interested In

• BP (BP) PT Raised to $43 at Piper Sandler
• D2M Biotherapeutics Announces First Patient Dosed in A Phase 1 Study Evaluating
• From the SEE Impact Report: Q&A With Arnaud Brunet